TipRanks
Eledon Pharmaceuticals (ELDN)
NASDAQ:ELDN
US Market
ELDN
Eledon Pharmaceuticals
RESEARCH TOOLSreports
Want to see ELDN full AI Analyst Report?

Eledon Pharmaceuticals (ELDN) Stock News & Sentiment

1,056 Followers
Eledon Therapeutics: Buy Rating Reaffirmed on Strong Cash Runway and Tegoprubart Data; Price Target Unchanged at $8
Premium
Ratings
Eledon Therapeutics: Buy Rating Reaffirmed on Strong Cash Runway and Tegoprubart Data; Price Target Unchanged at $8
2M ago
ELDN
Eledon’s BESTOW Trial Completion: What Tegoprubart Could Mean for Transplant Investing
Premium
Company Announcements
Eledon’s BESTOW Trial Completion: What Tegoprubart Could Mean for Transplant Investing
3M ago
ELDN
Eledon Pharmaceuticals Expands Authorized Shares After Stockholder Vote
Premium
Company Announcements
Eledon Pharmaceuticals Expands Authorized Shares After Stockholder Vote
4M ago
8K
ELDN
Analyst Reiterates Buy on Eledon as Tegoprubart Data Impresses; Price Target Maintained at $6
Premium
Ratings
Analyst Reiterates Buy on Eledon as Tegoprubart Data Impresses; Price Target Maintained at $6
4M ago
ELDN
Eledon Pharmaceuticals, Inc. (ELDN) Q4 Earnings Cheat Sheet
Premium
Pre-Earnings
Eledon Pharmaceuticals, Inc. (ELDN) Q4 Earnings Cheat Sheet
7M ago
ELDN
Compelling Tegoprubart Data in Type 1 Diabetes Transplantation Support Buy Rating on Eledon
Premium
Ratings
Compelling Tegoprubart Data in Type 1 Diabetes Transplantation Support Buy Rating on Eledon
7M ago
ELDN
Eledon Pharmaceuticals: Sustained Tegoprubart Efficacy, Differentiated Safety, and Upcoming Transplant Catalysts Support Buy Rating
Premium
Ratings
Eledon Pharmaceuticals: Sustained Tegoprubart Efficacy, Differentiated Safety, and Upcoming Transplant Catalysts Support Buy Rating
8M ago
ELDN
More ELDN News >

ELDN News on the Web

Eledon Pharmaceuticals (ELDN) Shares Rise on Positive Tegoprubart Trial Data and FDA Fast Track
GuruFocus News
Bullish
Wall Street Analysts Are Bullish on Top Healthcare Picks
TipRanks News
Bullish
Eledon Therapeutics: Buy Rating Reaffirmed on Strong Cash Runway and Tegoprubart Data; Price Target Unchanged at $8
TipRanks News
Bullish
Wall Street Analysts Are Bullish on Top Healthcare Picks
TipRanks News
Bullish
Natera, Eledon Partner On Kidney Transplant Monitoring Test For Phase 3 Trial; Stock Up
rttnews
Bullish
Analysts’ Top Healthcare Picks: Diamedica Therapeutics (DMAC), Guardian Pharmacy Services, Inc. Class A (GRDN)
TipRanks News
Bullish
Guggenheim Sticks to Its Buy Rating for Eledon Pharmaceuticals (ELDN)
TipRanks News
Bullish
Eledon Pharmaceuticals Expands Authorized Shares After Stockholder Vote
TipRanks News
Neutral

News Score - Last 7 Days

Not enough data to generate a sentiment score
Media Buzz
This Week0 articles
Weekly Average2 articles
News Sentiment
Currently, no data available
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is ELDN’s Media Buzz Sentiment?
Currently, no data Available
What is ELDN’s weekly average amount of articles?
In an average week, 2 articles about ELDN are published.
    What is ELDN’s News Sentiment?
    Currently, no data Available
    Healthcare Stocks that are Trending in the News
    REGNRegeneron
    QTTBQ32 Bio
    NVSNovartis
    RHHVFRoche Holding AG
    KRROKorro Bio
    Showing the stocks with the most bullish news sentiment over the past week